The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC

• Main Authors: Ji Li (Author), Min Wang (Author), Shuhui Xu (Author), Yuying Li (Author), Jiatong Li (Author), Jinming Yu (Author), Hui Zhu (Author)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Brain metastases are more and more common among patients with non-small cell lung cancer (NSCLC). TKI therapy could provide ideal outcomes for patients harboring epidermal growth factor receptor or ALK mutations. For wild-type patients, however, survival is poor because there are few effective treat...